Nanordica Medical
Tallinn
About Nanordica Medical
Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing. Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds (https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.9M
- Last round: Series Unknown (May 2024)
- Website: nanordica.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/nanordica-medical-87918 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.